
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 94.5 | 94.5 | 94.5 | 0 | 0 | CS |
4 | 0 | 0 | 94.5 | 94.5 | 94.5 | 0 | 0 | CS |
12 | 1.05 | 1.12359550562 | 93.45 | 96.95 | 89.95 | 36292 | 94.13601402 | CS |
26 | 4.55 | 5.05836575875 | 89.95 | 100.1 | 78.4 | 143555 | 92.25456688 | CS |
52 | 28 | 42.1052631579 | 66.5 | 105 | 56.35 | 333871 | 84.43239335 | CS |
156 | -486.85 | -83.7447320891 | 581.35 | 1134.525 | 43.75 | 259394 | 247.37099181 | CS |
260 | -885.5 | -90.3571428571 | 980 | 1134.525 | 43.75 | 216252 | 279.44212295 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions